CIK 0001612042 · Large accelerated filer
Ascendis Pharma A/S
Sign in to watch- Ticker
- ASND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Denmark
- Entity type
- other
- Phone
- 45 70 22 22 44
- Business address
- TUBORG BOULEVARD 12, HELLERUP, Denmark
- Open-market buys, last 90 days
- $492,654
- in 1 filing
- Open-market sales, last 90 days
- $872,905
- in 2 filings
Net −$380,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Bodenhoff Mads SVP & PAO | Option exercise | +3,000 | $110.00 | $330K | 3,000 |
| 2026-09-08 | Bodenhoff Mads SVP & PAO | Sale | −3,000 | $270.19 | $811K | 0 |
| 2026-09-08 | Bodenhoff Mads SVP & PAO | Option exercise · Warrants | −3,000 | 687 | ||
| 2026-09-02 | HOLTUG LARS Director | Sale | −236 | $264.13 | $62K | 4,000 |
| 2026-08-14 | BIENAIME JEAN JACQUES Director | Purchase | +1,100 | $245.85 | $270K | 2,000 |
| 2026-08-14 | BIENAIME JEAN JACQUES Director | Purchase | +900 | $246.91 | $222K | 2,900 |
| 2026-06-02 | SMITH SCOTT THOMAS EVP & Chief Financial Officer | Purchase | +100 | $219.00 | $22K | 4,367 |
| 2026-05-29 | BIENAIME JEAN JACQUES Director | Purchase | +200 | $223.76 | $45K | 600 |
| 2026-05-29 | BIENAIME JEAN JACQUES Director | Purchase | +200 | $222.30 | $44K | 800 |
| 2026-05-29 | BIENAIME JEAN JACQUES Director | Purchase | +100 | $223.50 | $22K | 900 |
| 2026-05-29 | SMITH SCOTT THOMAS EVP & Chief Financial Officer | Purchase | +250 | $223.32 | $56K | 4,267 |
| 2026-05-26 | BIENAIME JEAN JACQUES Director | Purchase | +200 | $236.24 | $47K | 200 |
| 2026-05-26 | BIENAIME JEAN JACQUES Director | Purchase | +200 | $239.37 | $48K | 400 |
| 2026-05-11 | JENSEN FLEMMING STEEN See Remarks | Sale | −19,460 | $238.49 | $4.6M | 0 |
| 2026-04-14 | BIENAIME JEAN JACQUES Director | Returned to the company · Warrants | −9,160 | 0 | ||
| 2026-04-14 | BIENAIME JEAN JACQUES Director | Grant or award · Warrants | +9,160 | 9,160 |
Page 1 of 1 · 16 trades